Llega a Espaa Mounjaro, el competidor de Ozempic contra la obesidad: cuesta 271 euros al mes y no est financiado El frmaco es el ms eficaz que hay aprobado para luchar contra una enfermedad crnica que sufren ms de 8,5 millones de personas, pero tambin el ms caro El 1 de julio las farmacias espaolas comenzarn a vender Mounjaro, el segundo frmaco de la familia de Ozempic que, adems de tener indicacin para la diabetes, tambin est aprobado contra la obesidad
Your dose may increase over weeks or months as your body responds to therapyPlexusDx's flat-rate pricing means you only pay $189/month regardless of dose adjustments
Mild side effects at low doses may make it easier for people to stick with the medication
While it does not directly predict itching, genetic insights into immune sensitivity and skin-barrier function can help clinicians personalize your treatment to reduce overall side effects, including dermatological reactions
Studies show that 20-40% of users experience some level of nausea or other GI symptoms, especially in the first weeks of treatment
